Summary
- Top of page
- Summary
- Introduction
- Results and discussion
- Conclusions
- Experimental procedures
- Acknowledgements
- References
- Supporting Information
The interaction of bacterial exopolysaccharides, produced by opportunistic lung pathogens, with antimicrobial peptides of the innate primate immune system was investigated. The exopolysaccharides were produced by Pseudomonas aeruginosa, Inquilinus limosus and clinical isolates of the Burkholderia cepacia complex, bacteria that are all involved in lung infections of cystic fibrosis patients. The effects of the biological activities of three orthologous cathelicidins from Homo sapiens sapiens, Pongo pygmaeus (orangutan) and Presbitys obscurus (dusky leaf monkey) were examined. Inhibition of the antimicrobial activity of peptides was assessed using minimum inhibitory concentration assays on a reference Escherichia coli strain in the presence and absence of exopolysaccharides, whereas complex formation between peptides and exopolysaccharides was investigated by means of circular dichroism, fluorescence spectroscopy and atomic force microscopy. Biological assays revealed that the higher the negative charge of exopolysaccharides the stronger was their inhibiting effect. Spectroscopic studies indicated the formation of molecular complexes of varying stability between peptides and exopolysaccharides, explaining the inhibition. Atomic force microscopy provided a direct visualization of the molecular complexes. A model is proposed where peptides with an α-helical conformation interact with exopolysaccharides through electrostatic and other non-covalent interactions.
Introduction
- Top of page
- Summary
- Introduction
- Results and discussion
- Conclusions
- Experimental procedures
- Acknowledgements
- References
- Supporting Information
Bacteria produce a number of polysaccharidic molecules that are exposed to the surrounding medium. Polysaccharides can be part of the external membrane (e.g. lipopolysaccharides of Gram-negative bacteria), can form a capsule around the microbe (capsular polysaccharides) or can be released into the extracellular medium (exopolysaccharides, EPS). In all cases, saccharidic macromolecules constitute an important interface between bacteria and their environment, a milieu essential for their own survival. This paper focuses on bacterial EPS.
Considering pathogenic bacteria, polysaccharides are involved in a large number of biological functions either promoted by their common structural properties (i.e. abundance of hydroxyl groups, hydrophilicity, etc.) or driven by specific chemical and conformational motifs of each EPS. As far as their common properties are concerned, EPS help constitute an environmental niche around bacteria or colonies serving to maintain the proper hydration, acting as a physical barrier against external threats and trapping useful micronutrients (Ophir and Gutnick, 1994). Together with other biomacromolecules, EPS form the skeleton of biofilms where bacterial colonies grow in organized communities, regulated by the switching on and off of specific genes. As a matter of fact, microorganisms able to produce large amount of EPS (mucoid strains) can be found after the onset of lung infection in cystic fibrosis patients, as reported for Pseudomonas aeruginosa (Deretic et al., 1990; Govan and Deretic, 1996) and for some species of the Burkholderia cepacia complex (Chung et al., 2003; Zlosnik et al., 2008).
More specific biological functions exhibited by bacterial polysaccharides have been investigated in recent studies. Pier et al. reported that acetylated alginate produced by P. aeruginosa prevented activation of the alternative pathway of the complement system and scavenged hypochlorite produced by activated phagocytes (Pier et al., 2001). O-acetyl substitution on EPS is believed to be used by bacteria to mask hydroxyl groups that are the binding site for opsonins C3b and C4b. Reckseidler-Zenteno et al. (2005) demonstrated a drastically reduced persistence in human serum of a mutant strain of Burkholderia pseudomallei unable to produce the capsular polysaccharide. Using immunofluorescence microscopy in the presence of antibodies for the human complement factor C3b, they demonstrated that the capsule contributes to resistance to phagocytosis by reducing C3b deposition on the surface of the bacterium. Finally, Brown and Gordon (2001) recognized the presence of a new dectin-like receptor on macrophages capable of binding β-(1→3) glucans. This shed new light on innate immune recognition of β-glucans, which exert potent effects on the immune system by stimulating anti-tumour and antimicrobial activity.
In order to further increase the understanding of the connections between bacteria and the innate immune system, this paper presents data on the interaction between EPS produced by opportunistic bacteria and antimicrobial peptides (AMP) from the cathelicidin family, which are secreted onto mucosal surfaces and stored in the granules of phagocytes (Ganz and Lehrer, 1998). The interaction of AMP with bacterial membranes leads to their disruption and eventually to cell death. The precise mechanism of action of cathelicidins has not yet been completely elucidated, although a model based on a ‘carpet’ interaction between AMP and bacterial membrane, possibly also involving the formation of ‘wormhole’ or toroidal pores, has been proposed (Dürr et al., 2006; Porcelli et al., 2008). Regardless the actual mechanism, AMP must in any case be free to interact with the cytoplasmic membrane. Interactions with (macro)molecules in the bacterial cell environment will modulate, and could jeopardize their biological action. Preliminary results on this topic have already been reported (Herasimenka et al., 2005) and a possible model of the molecular interaction of human and sheep cathelicidins with EPS, based on AMP association and complexation with the polysaccharide chain, was proposed. A more systematic study is now presented where human (hssLL-37), Pongo pygmaeus (ppyLL-37) and Presbytis obscurus (pobRL-37) orthologous of the α-helix forming cathelicidin LL-37, are investigated in the presence of EPS produced by bacteria involved in lung infections of cystic fibrosis patients. These orthologues vary in charge (from +4 to +10) and property for assuming a helical conformation in aqueous buffer (Zelezetsky et al., 2006). The primary structure, net positive charge and amphipatic properties of the AMP used are reported in Table 1. HssLL-37 and ppyLL-37 exhibit a moderate and low net positive charge (q) respectively, and possess a higher mean residue hydrophobicity (〈H〉) than the more highly cationic pobRL-37, whereas the amphipathicities (〈μHrel〉) are similar.
Table 1. Primary structure, net positive charge and amphypathic properties of cathelicidins used in this study | Cathelicidin | | +q | 〈H〉 | 〈μHrel〉 |
|---|
|
| Homo sapiens (hssLL-37) | LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES | 6 | −1.83 | 0.59 |
| Pongo pygmaeus (ppyLL-37) | LLGDFFRKAREKIGEEFKRIVQRIKDFLRNLVPRTES | 4 | −1.70 | 0.59 |
| Presbitys obscurus (pobRL-37) | RLGNEFRKAKKKIGRGLKKIGQKIKDFLGNLVPRTES | 10 | −2.12 | 0.62 |
Different EPS have been considered: (i) alginate produced by P. aeruginosa strain PAO1; (ii) cepacian produced by Burkholderia pyrrocinia strain BTS7 (Lagatolla et al., 2002); (iii) a mixture composed by a mannan and a glucan, both fully pyruvilated, produced by Inquilinus limosus, hereafter referred to as IL (Herasimenka et al., 2007); and (iv) a mixture of cepacian, PS-I and dextran, hereafter referred to as C9343, produced by Burkholderia cenocepacia strain C9343 (Conway et al., 2004). Cepacian is the EPS produced by the majority of the B. cepacia complex clinical isolates, either as the only EPS, or in a mixture with other different EPS, so that it can be considered as representative of this bacterial group. The primary structures of these EPS are reported in Fig. 1. Mixtures of different EPS cosynthesized by bacteria were also included in this study to try to asses how this characteristic influences the biological activity of EPS. It is worth mentioning that the above EPS are able to form polymer aggregates that contribute to the biofilm architecture, where acetyl groups play a stabilizing role (Nivens et al., 2001; Herasimenka et al., 2008).
In the present investigation, besides microbiological assays and physico-chemical studies, microscopy experiments, based on the powerful atomic force technique, were performed for a direct visualization of AMP–EPS interactions.
Conclusions
- Top of page
- Summary
- Introduction
- Results and discussion
- Conclusions
- Experimental procedures
- Acknowledgements
- References
- Supporting Information
The MIC experiments, together with a physico-chemical characterization of the interaction between AMP and EPS, produced by opportunistic bacteria, demonstrated that bacteria can use EPS to bind and segregate AMP, thus lowering the efficiency of the primary innate host defences.
Bacterial polysaccharides are often negatively charged, which certainly promotes their complexation with positively charged peptides. In fact, MIC and fluorescence experiments showed that alginate and the mixture of EPS produced by I. limosus, having one negative net charge per monosaccharide residue, lowered the biological activity of AMP and generated stable complexes in a wide range of EPS concentration. On the contrary, the charge of the peptide seemed not to have a relevant influence on the stability of the complexes. As a matter of fact, both ppyLL-37 (+4) and pobRL-37 (+10) peptides, which are quite different in terms of cationicity, exhibited similar fluorescence behaviour with respect to the EPS tested. In order to complex with EPS, the three investigated AMP need to assume an α-helical conformation, at least for a relatively long stretch of their primary structure. The electrolytic nature of EPS certainly helps peptides to undergo the coil-to-helix conformational transition by increasing the ionic strength and thus lowering repulsions between homologous electric charges. However, CD experiments indicated that specific stereochemical motifs may also play a role in the interaction between EPS and AMP. Although both alginate and IL have a linear polymer structure with one negative charge per saccharidic unit, they behaved differently in the presence of different peptides. Alginate and IL were equally efficient in segregating pobRL-37, and exhibited almost the same efficiency with hssLL-37, but showed a very different behaviour in the presence of ppyLL-37. Here, at high EPS concentration, IL induced almost the same α-helical content as that in the absence of EPS, while alginate supported the ppyLL-37 helical structure. Some considerations on the differences in the conformations of alginate and IL polymers might help to explain this different behaviour. The 1→4 glycosidic linkages in alginate lead to an elongated conformation that can be classified as ‘cellulosic type’. Contrary to this, the 1→2 and 1→3 glycosidic bonds present in the EPS produced by I. limosus force the polymer chain to assume a more ‘helicoidal’ conformation.
Finally, AFM revealed itself to be a potent tool to visualize the interaction of EPS with AMP. Although the experimental conditions generally used for AFM are rather different from those present in vivo or used in vitro for different experiments, the comparison between images of EPS obtained in the absence and in the presence of AMP were very indicative of the presence of supramolecular aggregates, which may conveniently explain some details of the structure–function relationships governing the biological activities of bacterial EPS.
Acknowledgements
- Top of page
- Summary
- Introduction
- Results and discussion
- Conclusions
- Experimental procedures
- Acknowledgements
- References
- Supporting Information
Professor D.P. Speert (Department of Pediatrics, University of British Columbia, Vancouver, Canada) is kindly acknowledged for the EPS mixture produced by B. cenocepacia strain C9343. We are grateful to Professor J. Govan (Centre for Infectious Diseases, University of Edinburgh, Scotland) and Professor P. Vandamme (Laboratory of Microbiology, University of Gent, Belgium) for the strains P. aeruginosa PAO1 and I. limosus LMG 20952T respectively. Professor M. Prato (Department of Pharmaceutical Sciences, University of Trieste, Italy) is kindly acknowledged for the use of the AFM instrumentation. This work was carried out with the financial support of the Regione Friuli Venezia Giulia (projects # L.R.11/2003 and L.R.26/2005), of the Italian Ministry of the University and Research (PRIN 2007) and of the Italian Cystic Fibrosis Foundation (project #11/2006, with the contribution of CF delegation of Belluno, Italy).